GEN · NZX

General Capital

Covered: HY23 - FY232 published briefings

General Capital is an NZX-listed company covered by Annolyse across HY23 - FY23. This page brings together the latest briefing, the current metrics snapshot, and the published history to date in one place.

Snapshot

Latest metrics

FY23, released 29 May 2023

MetricValue
Revenue$7700.3m
NPAT$2258.2m
Net debt$95813.8m
ROE %9.3%
PBT$3344.1m
Total assets$136087.9m

Longitudinal view

Performance over time

Current-period values from each published briefing, with the most recent reporting period shown first.

← Swipe to view more
MetricFY2312 MONTHS29 May 2023HY236 MONTHS29 November 2022
Revenue$7700.3m$3450.8m
Revenue growth %71.7%94.7%
PBT$3344.1m$1539.9m
PBT growth %77.1%
NPAT$2258.2m$1038.7m
NPAT growth %68.4%
ROE %9.3%8.3%
Net debt$95813.8m
Total assets$136087.9m$126336.1m

Reference: annolyse.ai/companies/gen

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Metric trajectory

Small multiples turn the table into a trend view while keeping the table above as the primary reference.

Revenue

Reported revenue across covered periods.

NPAT

Statutory profit after tax.

ROE

Return on equity.

Net debt

Borrowings less cash; negative values indicate net cash.

Accountability

What changed versus the prior briefing

Read the prior briefing's expectations and unresolved questions alongside the subsequent result, without forcing long-form editorial text into narrow cards.

Prior Expectations

HY23

From Swung to NZ$1.0m profit as net revenue nearly doubled and assets grew 53%

No quantified forward-work, deposit-book, or earnings target was disclosed. The only shape context available is that HY22 was a loss-making half of a profitable FY22 (HY22 NPAT was ‑27% of full-year NPAT), implying a 2H-weighted pattern in FY22. Against that anchor, HY23 net revenue annualises to roughly NZ$6.9m, or about 54% above FY22 reported revenue of NZ$4.5m. That establishes a meaningfully higher run-rate but says nothing about whether FY23 repeats the same 2H skew. The release does not support or refute a specific full-year profit shape.

Prior Unresolved

HY23

  • What is the HY23 deposit book and gross-borrowings balance, and has the deposit-to-equity ratio deepened alongside asset growth?
  • What is operating cash flow, and does it corroborate the accrual swing to profit?
  • Is the BB- credit rating referenced in prior periods unchanged, and are there any covenant or regulatory capital constraints near binding levels?
  • What is management's plan for the loss-making Research & Advisory and Corporate & Other segments, given they absorb a meaningful share of Finance-segment profit?
  • Are there concentration risks in the lending book that could become material as assets scale?

This briefing cannot assess cash generation, leverage trajectory, or valuation because operating cash flow, HY23 gross borrowings/net debt, and NTA per share were not disclosed in the supplied data.

Archive

Briefing archive

Every published Annolyse briefing for this company appears here in reverse chronological order.

Email updates

Want the next General Capital briefing delivered to your inbox?

Get future Annolyse briefings by email as soon as they are published.